Posted By: National Institutes of Health
Partners: HHS/Biomedical Advanced Research and Development Authority (BARDA), HHS/NIH/National Institute of Allergy and Infectious Diseases (NIAID) Submission Dates: 9 a.m. ET, Sep 08, 2016 - 11:59 p.m. ET, Jan 09, 2017 Winners Announced: Mar 27, 2017
Note: Phase 1 is now closed. However, applicants are eligible to submit a prototype for Phase 2, even if they did not submit a concept for Phase 1. In addition, no letter of intent is required for Phase 2. The deadline for Phase 2 is September 4, 2018. If you have any questions or difficulties, please contact Susan Kerin with Capital Consulting Corporation (the logistics contractor) at firstname.lastname@example.org.
Here are some general details on the challenge. The full challenge can be found at http://www.cccinnovationcenter.com/challenges/antimicrobial-resistance-diagnostic-challenge/
Can you help create a diagnostic tool for health care providers to better identify resistant bacterial infections?
$20 million in prize awards
The main purpose of the Antimicrobial Resistance Diagnostic Challenge is to incentivize the development of one or more rapid, point-of-care in vitro diagnostic tests that would be of significant clinical and public health utility to combat the development and spread of antibiotic resistant bacteria or diagnostic tests that distinguish between bacterial and viral infections. The 18 specific drug-resistant bacteria are identified in Table 3 of the National Action Plan for Combating Antibiotic-Resistant Bacteria .